Pathological findings following radical prostatectomy in patients who are candidates for active surveillance: Impact of varying PSA levels

Dong Il Kang, Thomas L. Jang, Jeongyun Jeong, Eun Young Choi, Kelly Johnson, Dong Hyeon Lee, Wun Jae Kim, Isaac Kim

Research output: Contribution to journalReview article

10 Citations (Scopus)

Abstract

Active surveillance is an acceptable treatment option in men with a low-risk prostate cancer. In the present study, we have retrospectively reviewed the outcomes of 509 men who fit the criteria for active surveillance but selected radical prostatectomy. Then, the impact of varying prostate-specific antigen (PSA) levels on the risk of upstaging and upgrading in these patients was assessed. Pathological characteristics of patients who fulfilled the inclusion criteria under three active surveillance criteriathose of the University of California-San Francisco, the National Cancer Institute and the European Association of Urologywere examined. The proportion of men who were deemed candidates for active surveillance but were subsequently upstaged or upgraded was determined. Of 509 patients, 186 (36.5%), 132 (25.9%) and 88 (17.3%) men fulfilled the active surveillance criteria, respectively. Upgrading (Gleason scores 7-10) ranged from 32.8% to 38.6%, while upstaging (pT3) ranged from 10.2% to 12.5%, depending on the three active surveillance criteria. After a median follow-up of 24 months, three patients developed a biochemical recurrence. When the impact of varying PSA levels was examined using a test for trend analysis in the context of PSA for each protocol, rates of upstaging were lower in men with PSA <4ng ml -1. However, there was no impact of varying PSA levels on upgrading. In conclusion, commonly used active surveillance protocols carry the risks of upgrading and upstaging. More reliable and accurate markers are needed to better stratify the risks of men who are appropriate candidates for active surveillance.

Original languageEnglish (US)
Pages (from-to)838-841
Number of pages4
JournalAsian Journal of Andrology
Volume13
Issue number6
DOIs
StatePublished - Nov 1 2011

Fingerprint

Prostate-Specific Antigen
Prostatectomy
San Francisco
National Cancer Institute (U.S.)
Neoplasm Grading
Prostatic Neoplasms
Recurrence

All Science Journal Classification (ASJC) codes

  • Urology

Keywords

  • prostate-specific antigen
  • prostatectomy
  • prostatic neoplasm
  • risk

Cite this

Kang, Dong Il ; Jang, Thomas L. ; Jeong, Jeongyun ; Choi, Eun Young ; Johnson, Kelly ; Lee, Dong Hyeon ; Kim, Wun Jae ; Kim, Isaac. / Pathological findings following radical prostatectomy in patients who are candidates for active surveillance : Impact of varying PSA levels. In: Asian Journal of Andrology. 2011 ; Vol. 13, No. 6. pp. 838-841.
@article{efa9f3c71e4d46e59b189e058e2519de,
title = "Pathological findings following radical prostatectomy in patients who are candidates for active surveillance: Impact of varying PSA levels",
abstract = "Active surveillance is an acceptable treatment option in men with a low-risk prostate cancer. In the present study, we have retrospectively reviewed the outcomes of 509 men who fit the criteria for active surveillance but selected radical prostatectomy. Then, the impact of varying prostate-specific antigen (PSA) levels on the risk of upstaging and upgrading in these patients was assessed. Pathological characteristics of patients who fulfilled the inclusion criteria under three active surveillance criteriathose of the University of California-San Francisco, the National Cancer Institute and the European Association of Urologywere examined. The proportion of men who were deemed candidates for active surveillance but were subsequently upstaged or upgraded was determined. Of 509 patients, 186 (36.5{\%}), 132 (25.9{\%}) and 88 (17.3{\%}) men fulfilled the active surveillance criteria, respectively. Upgrading (Gleason scores 7-10) ranged from 32.8{\%} to 38.6{\%}, while upstaging (pT3) ranged from 10.2{\%} to 12.5{\%}, depending on the three active surveillance criteria. After a median follow-up of 24 months, three patients developed a biochemical recurrence. When the impact of varying PSA levels was examined using a test for trend analysis in the context of PSA for each protocol, rates of upstaging were lower in men with PSA <4ng ml -1. However, there was no impact of varying PSA levels on upgrading. In conclusion, commonly used active surveillance protocols carry the risks of upgrading and upstaging. More reliable and accurate markers are needed to better stratify the risks of men who are appropriate candidates for active surveillance.",
keywords = "prostate-specific antigen, prostatectomy, prostatic neoplasm, risk",
author = "Kang, {Dong Il} and Jang, {Thomas L.} and Jeongyun Jeong and Choi, {Eun Young} and Kelly Johnson and Lee, {Dong Hyeon} and Kim, {Wun Jae} and Isaac Kim",
year = "2011",
month = "11",
day = "1",
doi = "10.1038/aja.2011.54",
language = "English (US)",
volume = "13",
pages = "838--841",
journal = "Asian Journal of Andrology",
issn = "1008-682X",
publisher = "Nature Publishing Group",
number = "6",

}

Pathological findings following radical prostatectomy in patients who are candidates for active surveillance : Impact of varying PSA levels. / Kang, Dong Il; Jang, Thomas L.; Jeong, Jeongyun; Choi, Eun Young; Johnson, Kelly; Lee, Dong Hyeon; Kim, Wun Jae; Kim, Isaac.

In: Asian Journal of Andrology, Vol. 13, No. 6, 01.11.2011, p. 838-841.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Pathological findings following radical prostatectomy in patients who are candidates for active surveillance

T2 - Impact of varying PSA levels

AU - Kang, Dong Il

AU - Jang, Thomas L.

AU - Jeong, Jeongyun

AU - Choi, Eun Young

AU - Johnson, Kelly

AU - Lee, Dong Hyeon

AU - Kim, Wun Jae

AU - Kim, Isaac

PY - 2011/11/1

Y1 - 2011/11/1

N2 - Active surveillance is an acceptable treatment option in men with a low-risk prostate cancer. In the present study, we have retrospectively reviewed the outcomes of 509 men who fit the criteria for active surveillance but selected radical prostatectomy. Then, the impact of varying prostate-specific antigen (PSA) levels on the risk of upstaging and upgrading in these patients was assessed. Pathological characteristics of patients who fulfilled the inclusion criteria under three active surveillance criteriathose of the University of California-San Francisco, the National Cancer Institute and the European Association of Urologywere examined. The proportion of men who were deemed candidates for active surveillance but were subsequently upstaged or upgraded was determined. Of 509 patients, 186 (36.5%), 132 (25.9%) and 88 (17.3%) men fulfilled the active surveillance criteria, respectively. Upgrading (Gleason scores 7-10) ranged from 32.8% to 38.6%, while upstaging (pT3) ranged from 10.2% to 12.5%, depending on the three active surveillance criteria. After a median follow-up of 24 months, three patients developed a biochemical recurrence. When the impact of varying PSA levels was examined using a test for trend analysis in the context of PSA for each protocol, rates of upstaging were lower in men with PSA <4ng ml -1. However, there was no impact of varying PSA levels on upgrading. In conclusion, commonly used active surveillance protocols carry the risks of upgrading and upstaging. More reliable and accurate markers are needed to better stratify the risks of men who are appropriate candidates for active surveillance.

AB - Active surveillance is an acceptable treatment option in men with a low-risk prostate cancer. In the present study, we have retrospectively reviewed the outcomes of 509 men who fit the criteria for active surveillance but selected radical prostatectomy. Then, the impact of varying prostate-specific antigen (PSA) levels on the risk of upstaging and upgrading in these patients was assessed. Pathological characteristics of patients who fulfilled the inclusion criteria under three active surveillance criteriathose of the University of California-San Francisco, the National Cancer Institute and the European Association of Urologywere examined. The proportion of men who were deemed candidates for active surveillance but were subsequently upstaged or upgraded was determined. Of 509 patients, 186 (36.5%), 132 (25.9%) and 88 (17.3%) men fulfilled the active surveillance criteria, respectively. Upgrading (Gleason scores 7-10) ranged from 32.8% to 38.6%, while upstaging (pT3) ranged from 10.2% to 12.5%, depending on the three active surveillance criteria. After a median follow-up of 24 months, three patients developed a biochemical recurrence. When the impact of varying PSA levels was examined using a test for trend analysis in the context of PSA for each protocol, rates of upstaging were lower in men with PSA <4ng ml -1. However, there was no impact of varying PSA levels on upgrading. In conclusion, commonly used active surveillance protocols carry the risks of upgrading and upstaging. More reliable and accurate markers are needed to better stratify the risks of men who are appropriate candidates for active surveillance.

KW - prostate-specific antigen

KW - prostatectomy

KW - prostatic neoplasm

KW - risk

UR - http://www.scopus.com/inward/record.url?scp=80755127204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80755127204&partnerID=8YFLogxK

U2 - 10.1038/aja.2011.54

DO - 10.1038/aja.2011.54

M3 - Review article

C2 - 21785442

AN - SCOPUS:80755127204

VL - 13

SP - 838

EP - 841

JO - Asian Journal of Andrology

JF - Asian Journal of Andrology

SN - 1008-682X

IS - 6

ER -